Press release content from Globe Newswire. The AP news staff was not involved in its creation.
CLOV FILING DEADLINE TOMORROW: Bernstein Liebhard LLP Reminds Investors of the Deadline to File .
Bernstein Liebhard LLPApril 5, 2021 GMT
NEW YORK, April 05, 2021 (GLOBE NEWSWIRE) Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Clover Health Investments Corp. (“Clover” or the “Company”) (NASDAQ: CLOV) from October 6, 2020 and February 4, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Middle District of Tennessee alleges violations of the Securities Exchange Act of 1934.
Kaskela Law LLC Announces Important Deadline in Shareholder Class Action Lawsuit Against Clover Health Investments Corp (CLOV) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
(SPCE), Gamestop Corporation (NYSE:GME) - Chamath Palihapitiya And His Rise As A FinTwit Influencer
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, March 10, 2021 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of AstraZeneca PLC (NASDAQ: AZN), iRhythm Technologies, Inc. (NASDAQ: IRTC), Tyson Foods, Inc. (NYSE: TSN), and Clover Health Investments Corp. (NASDAQ: CLOV, CLOVW). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. AstraZeneca PLC (NASDAQ: AZN) Class Period: May 21, 2020 to November 20, 2020 Lead Plaintiff Deadline: March 29, 2021 AstraZeneca is one of the largest biopharmaceutical companies in the world and was one of the early front-runners in the race to develop a COVID-19 vaccine. In April 2020, the Company partnered with Oxford University to develop a potential recombinant adenovirus vaccine for the virus, later dubbed AZD1222. On November 23, 2020, Ast